Tianjin Tianyao Pharmaceuticals (600488.SH) announced that its subsidiary, Tianjin Tianyao Heping Pharmaceutical Co., Ltd. (referred to as 'Tianyao Heping'), received the Supplementary Approval Notice for Injection Methylprednisolone Sodium Succinate (20mg) issued by the National Medical Products Administration. The drug has been approved for consistency evaluation of generic drug quality and efficacy. Injection Methylprednisolone Sodium Succinate is a glucocorticoid drug mainly used for anti-inflammatory treatment, immunosuppressive treatment, treatment of blood diseases and tumors, treatment of shock, etc.
Tianjin Tianyao Pharmaceuticals (600488.SH) announced that its subsidiary, Tianjin Tianyao Heping Pharmaceutical Co., Ltd. (referred to as 'Tianyao Heping'), received the Supplementary Approval Notice for Injection Methylprednisolone Sodium Succinate (20mg) issued by the National Medical Products Administration. The drug has been approved for consistency evaluation of generic drug quality and efficacy. Injection Methylprednisolone Sodium Succinate is a glucocorticoid drug mainly used for anti-inflammatory treatment, immunosuppressive treatment, treatment of blood diseases and tumors, treatment of shock, etc.